06/12/2026
Could psilocybin help change the future of Alzheimer's treatment?
A fascinating case report published in *Frontiers in Neuroscience* documented an 80-year-old woman with advanced Alzheimer's disease who experienced significant improvements following medically supervised psilocybin treatment.
Prior to treatment, she had lived with Alzheimer's for nearly a decade. She was largely non-verbal, required full-time care, experienced urinary incontinence, and struggled with daily functioning.
Following a supervised dose of psilocybin, researchers observed something remarkable.
Within about 24 hours, she began speaking in full sentences, engaging in conversations, recalling personal memories, recognizing family members, and displaying greater emotional responsiveness.
Researchers also observed improvements in mobility, self-care, and continence.
A second dose administered one month later was associated with additional improvements in communication, engagement, and overall quality of life.
As a Somatic Depth Psychologist, I find studies like this both fascinating and hopeful. They challenge long-held assumptions about the brain's capacity for change, even later in life.
However, it is important to remain scientifically grounded.
This was a single case report, not a large clinical trial.
While the results are extraordinary, much more research is needed before scientists can determine whether these outcomes can be consistently replicated across larger populations.
What we do know is that psilocybin continues to show promise in research involving depression, PTSD, addiction, end-of-life anxiety, and neuroplasticity.
Hope is important.
So is caution.
Psilocybin should never be viewed as a miracle cure and should only be used in appropriate clinical settings with professional screening and professional guidance.
👇 What are your thoughts on psychedelic-assisted therapy and its future role in mental health care?
❤️ Check the comments for more information about emerging psilocybin research.